Microbot Medical Inc.
Microbot Medical Inc. (MBOT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · MBOT · as of Sep 30, 2025
Ownership Breakdown
74
Institutional Holders
▲ 21 vs Q2
$31.79M
Total Inst. Value
▲ $20.74M vs Q2
45.57M
Shares Outstanding
freeFloat 99.95%
10.42M
13F Shares Held
▲ 6.03M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
MBOT largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC biological products, (no diagnostic substances) | 2.34M | 6.42% | 6.42% | $7.15B | Nov 7, 2025 | ▲ 292.9K |
CIBC PRIVATE WEALTH GROUP, LLC biological products, (no diagnostic substances) | 1.45M | 3.98% | 3.98% | $4.43B | Nov 24, 2025 | ▲ 842.0K |
biological products, (no diagnostic substances) | 1.45M | 3.98% | 3.98% | $4.43B | Nov 12, 2025 | NEW |
SUSQUEHANNA INTERNATIONAL GROUP, LLP biological products, (no diagnostic substances) | 1.25M | 3.43% | 3.43% | $3.81B | Nov 14, 2025 | ▲ 1.22M |
HEIGHTS CAPITAL MANAGEMENT, INC biological products, (no diagnostic substances) | 883.1K | 2.42% | 2.42% | $2.69B | Nov 18, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 493.4K | 1.35% | 1.35% | $1.51B | Nov 12, 2025 | ▲ 98.3K |
BLACKROCK, INC. biological products, (no diagnostic substances) | 490.2K | 1.34% | 1.34% | $1.50B | Nov 12, 2025 | ▲ 169.0K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP biological products, (no diagnostic substances) | 293.3K | 80.38% | 80.38% | $894.57M | Nov 14, 2025 | ▲ 263.3K |
DNB ASSET MANAGEMENT AS biological products, (no diagnostic substances) | 243.6K | 66.77% | 66.77% | $743.07M | Nov 12, 2025 | ▲ 50.8K |
CITADEL ADVISORS LLC biological products, (no diagnostic substances) | 242.7K | 66.51% | 66.51% | $740.24M | Nov 14, 2025 | ▲ 154.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
26
Increased
+3.89M shares18
New Positions
first time holders3
Decreased
−289.5K shares0
Sold Out
fully exitedNet shares change (top 50)
+3.60M
+3.89M / −289.5K
Net new holders
+41
18 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
MBOT insider trading · insider activity
Source: SEC Form 4
6
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Stockburger Aileen Ptucha director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Madden Martin J. director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Wenderow Tal Baruch director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Wilson David James director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Burell Scott R director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Laxminarain Prattipati director | Apr 1, 2026 | Award | 10,000 | $2.37 | $23.7K | 10.0K | Form 4 ↗ |
Gadot Harel Chairman, President and CEO | Feb 18, 2026 | Award | 480,000 | $2.10 | $1.01M | 480.0K | Form 4 ↗ |
Diaz-Cartelle Juan Chief Medical Officer | Feb 18, 2026 | Award | 105,000 | $2.10 | $220.5K | 105.0K | Form 4 ↗ |
Sharon Simon General Manager, CTO | Feb 18, 2026 | Award | 105,000 | $2.10 | $220.5K | 105.0K | Form 4 ↗ |
Vaknin Rachel Chief Financial Officer | Feb 18, 2026 | Award | 105,000 | $2.10 | $220.5K | 105.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Microbot Medical Inc. (MBOT) is primarily owned by institutional investors, who hold approximately 22.9% of total shares outstanding. Company insiders own approximately 0.05%, while retail and public investors account for the remaining 77.08%.
The largest institutional shareholder of Microbot Medical Inc. is VANGUARD GROUP INC, holding approximately 2.34 million shares — equal to 6.42% of outstanding shares — as of September 30, 2025.
A total of 74 institutional investors currently hold MBOT stock, with a combined institutional value of approximately $31,792,781 as of the most recent 13F filing period.
Frequently asked questions
MBOT ownershipMicrobot Medical Inc. (MBOT) is primarily owned by institutional investors, who hold approximately 22.9% of shares. The largest shareholder is VANGUARD GROUP INC with a 6.42% stake. Company insiders hold 0.05%. Data sourced from SEC Form 13F as of September 30, 2025.